Esticast Logo
Get In Touch!

Anticoagulants Market By Administration Type ( Oral, Injectable ), By Drug Type ( Factor Xa inhibitors, DTIs, Heparin, Vitamin K Antagonists ), Industry Trends, Estimation & Forecast, 2017 - 2025

  • Published On: Feb, 2019
  • Category: Healthcare
  • Pages: 168
Anticoagulants Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Market Overview:

Anticoagulants, are the chemical substances, which are used as a blood thinner, in order to curb the occurrence or increase of unwanted blood clots. These anticoagulants restricts the secretion of Vitamin K enzymes, typically called as vitamin K epoxide reductase which causes the clotting of blood. Oral anticoagulants have emerged out to be the most adopted anticoagulants all over the globe owing to its high efficacy and being noble way of treatment without any incisions. In the current scenario, thromboembolism is spreading with a fast pace globally. Anticoagulants have emerged out to be the most efficient medication therapy for the patients suffering with venous embolism, prosthetic heart valves, atrial fibrillation, and acute myocardial infarction. A high risk of stroke among the people falling in the age group of 40-60 years is a major factor which is propelling the demand for anticoagulants globally. Moreover, a continuous hike in prevalence of atrial fibrillation, especially among geriatric population, is also fueling the market growth. A major factor which is attracting the patients towards these drugs is that they have emerged out as the best alternative to the surgical AF treatment. In addition to this, rapidly growing obesity among youth and mid-aged population is also a major cause of cardiac disorders. VTE is one of the most common vascular disorders in the United States and Europe and is associated with significant mortality. As per American Heart Association, people having obesity have 2 times higher risk of VTE as compared to the people with balanced BMI. An estimate of nearly 60,000-100,000 Americans die of cardiac disorders each year. Continuously spreading awareness regarding cardiac health and favorable government initiatives would emerge out as the future growth opportunities for the very market. The report provides detailed qualitative and quantitative analysis of the Global Anticoagulants Market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely administration type and drug type in each of the major regions.

Anticoagulants Market Segmentation

By Administration Type • Oral • Injectable By Drug Type • Factor Xa inhibitors • DTIs • Heparin • Vitamin K Antagonists By Geography • North America o U.S. o Canada o Mexico • Europe o U.K. o France o Germany o Italy o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Korea o Rest of APAC • South America o Brazil o Rest of South America • Rest of the World o Middle East o Africa

CHAPTER 1. INTRODUCTION 1.1. RESEARCH METHODOLOGY 1.1.1. ERC desk research 1.1.2. ERC data synthesis 1.1.3. Data validation and market feedback 1.1.4. ERC data sources CHAPTER 2. ANTICOAGULANTS MARKET OVERVIEW 2.1. ANTICOAGULANTS MARKET INTRODUCTION 2.2. GLOBAL ANTICOAGULANTS MARKET PRODUCTION AND GROWTH RATE, 2017-2025 2.2.1. Global Anticoagulants Production (VOLUME) and Growth Rate (%), (2017-2025) 2.3. GLOBAL ANTICOAGULANTS MARKET CAPACITY AND GROWTH RATE, 2017-2025 2.3.1. Global Anticoagulants Capacity (VOLUME) and Growth Rate (%), (2017-2025) 2.4. GLOBAL ANTICOAGULANTS MARKET REVENUE AND GROWTH RATE, 2017-2025 2.4.1. Global Anticoagulants Market Revenue (Million USD) and Growth Rate (%), (2017-2025) 2.5. GLOBAL ANTICOAGULANTS MARKET CONSUMPTION AND GROWTH RATE, 2017-2025 2.5.1. Global Anticoagulants Consumption (VOLUME) and Growth Rate (%), (2017-2025) 2.6. GLOBAL ANTICOAGULANTS MARKET PRICE TREND, 2017-2025 2.6.1. Global Anticoagulants Market Price Trend and Growth Rate (%), (2017-2025) CHAPTER 3. GLOBAL ANTICOAGULANTS MARKET BY ADMINISTRATION TYPE, 2017-2025 3.1. ORAL 3.2. INJECTABLE 3.3. GLOBAL ANTICOAGULANTS MARKET REVENUE BY ADMINISTRATION TYPE, 2017-2025 3.3.1. Global Anticoagulants Market Revenue (Million USD) and Share (%) By Administration type, 2017-2025 3.3.2. Oral Market Revenue and Growth Rate, 2017-2025 3.3.3. Injectable Market Revenue and Growth Rate, 2017-2025 3.4. GLOBAL ANTICOAGULANTS MARKET PRODUCTION BY ADMINISTRATION TYPE, 2017-2025 3.4.1. Global Anticoagulants Market Production (Volume) and Share (%) By Administration type, 2017-2025 3.4.2. Oral Market Production and Growth Rate, 2017-2025 3.4.3. Injectable Market Production and Growth Rate, 2017-2025 CHAPTER 4. GLOBAL ANTICOAGULANTS MARKET BY DRUG TYPE, 2017-2025 4.1. FACTOR XA INHIBITORS 4.2. DTIS 4.3. VITAMIN K ANTAGONISTS 4.4. GLOBAL ANTICOAGULANTS MARKET REVENUE BY DRUG TYPE, 2017-2025 4.4.1. Global Anticoagulants Market Revenue (Million USD) and Share (%) By Drug Type, 2017-2025 4.4.2. Factor Xa inhibitors Market Revenue and Growth Rate, 2017-2025 4.4.3. DTIs Market Revenue and Growth Rate, 2017-2025 4.4.4. Vitamin K Antagonists Market Revenue and Growth Rate, 2017-2025 4.5. GLOBAL ANTICOAGULANTS MARKET CONSUMPTION BY DRUG TYPE, 2017-2025 4.5.1. Global Anticoagulants Market Consumption (Volume) and share (%) By Drug Type, 2017-2025 4.5.2. Factor Xa inhibitors Market Consumption and Growth Rate, 2017-2025 4.5.3. DTIs Market Consumption and Growth Rate, 2017-2025 4.5.4. Vitamin K Antagonists Market Consumption and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for other drug type segment. CHAPTER 5. GLOBAL ANTICOAGULANTS MARKET BY REGION, 2017-2025 5.1. NORTH AMERICA 5.1.1. U.S. 5.1.2. Canada 5.1.3. Mexico 5.2. EUROPE 5.2.1. U.K. 5.2.2. France 5.2.3. Germany 5.2.4. Italy 5.2.5. Spain 5.2.6. Rest of Europe 5.3. ASIA PACIFIC 5.3.1. China 5.3.2. Japan 5.3.3. India 5.3.4. Korea 5.3.5. Rest of APAC 5.4. SOUTH AMERICA 5.4.1. Brazil 5.4.2. Rest of South America 5.5. REST OF THE WORLD 5.5.1. Middle East 5.5.2. Africa 5.6. GLOBAL ANTICOAGULANTS MARKET REVENUE BY REGION, 2017-2025 5.6.1. Global Anticoagulants Market Revenue (Million USD) and Share (%) By Region, 2017-2025 5.6.2. North America Market Revenue and Growth Rate, 2017-2025 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025 5.6.5. South America Market Revenue and Growth Rate, 2017-2025 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025 CHAPTER 6. GLOBAL ANTICOAGULANTS MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025 6.1. GLOBAL ANTICOAGULANTS MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025 6.1.1. Global Anticoagulants Market Production (Volume) and Share (%) By Region, 2017-2025 6.1.2. Global Anticoagulants Market Consumption (Volume) and Share (%) By Region, 2017-2025 6.1.3. North America Market Production and Consumption, 2017-2025 6.1.4. Europe Market Production and Consumption, 2017-2025 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025 6.1.6. South America Market Production and Consumption, 2017-2025 6.1.7. Rest of the World Market Production and Consumption, 2017-2025 CHAPTER 7. MARKET DETERMINANTS 7.1. MARKET DRIVERS 7.2. MARKET RESTRAINTS 7.3. MARKET OPPORTUNITIES 7.4. MARKET DETERMINANTS RADAR CHART CHAPTER 8. GLOBAL ANTICOAGULANTS MARKET COMPETITION BY MANUFACTURERS 8.1. GLOBAL ANTICOAGULANTS PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025) 8.1.1. Global Anticoagulants Production (VOLUME) and Share (%) by Manufacturers (2017-2025) 8.2. GLOBAL ANTICOAGULANTS REVENUE AND SHARE BY MANUFACTURERS (2017-2025) 8.2.1. Global Anticoagulants Revenue (Million USD) and Share (%) by Manufacturers (2017-2025) 8.3. ANTICOAGULANTS MARKET COMPETITIVE SITUATION AND TRENDS 8.3.1. Anticoagulants Market Share (%) of Top 3 Manufacturers 8.3.2. Anticoagulants Market Share (%) of Top 5 Manufacturers CHAPTER 9. GLOBAL ANTICOAGULANTS MANUFACTURERS ANALYSIS 9.1. BAYER HEALTHCARE 9.1.1. Business Overview 9.1.2. Company Basic Information 9.1.3. Anticoagulants Product Details 9.1.4. Bayer HealthCare Anticoagulants Production, Revenue and Gross Margin 9.2. BOEHRINGER INGELHEIM 9.2.1. Business Overview 9.2.2. Company Basic Information 9.2.3. Anticoagulants Product Details 9.2.4. Boehringer Ingelheim Anticoagulants Production, Revenue and Gross Margin 9.3. BRISTOL-MYERS SQUIBB 9.3.1. Business Overview 9.3.2. Company Basic Information 9.3.3. Anticoagulants Product Details 9.3.4. Bristol-Myers Squibb Anticoagulants Production, Revenue and Gross Margin 9.4. DAIICHI SANKYO 9.4.1. Business Overview 9.4.2. Company Basic Information 9.4.3. Anticoagulants Product Details 9.4.4. Daiichi Sankyo Anticoagulants Production, Revenue and Gross Margin 9.5. JOHNSON & JOHNSON 9.5.1. Business Overview 9.5.2. Company Basic Information 9.5.3. Anticoagulants Product Details 9.5.4. Johnson & Johnson Anticoagulants Production, Revenue and Gross Margin 9.6. SANOFI 9.6.1. Business Overview 9.6.2. Company Basic Information 9.6.3. Anticoagulants Product Details 9.6.4. Sanofi Anticoagulants Production, Revenue and Gross Margin 9.7. ABBOTT LABORATORIES 9.7.1. Business Overview 9.7.2. Company Basic Information 9.7.3. Anticoagulants Product Details 9.7.4. Abbott Laboratories Anticoagulants Production, Revenue and Gross Margin 9.8. ASTRAZENECA PLC 9.8.1. Business Overview 9.8.2. Company Basic Information 9.8.3. Anticoagulants Product Details 9.8.4. Astrazeneca plc Anticoagulants Production, Revenue and Gross Margin 9.9. MERCK & CO., INC. 9.9.1. Business Overview 9.9.2. Company Basic Information 9.9.3. Anticoagulants Product Details 9.9.4. Merck & Co., Inc. Anticoagulants Production, Revenue and Gross Margin 9.10. GENENTECH INC. 9.10.1. Business Overview 9.10.2. Company Basic Information 9.10.3. Anticoagulants Product Details 9.10.4. Genentech Inc. Anticoagulants Production, Revenue and Gross Margin CHAPTER 10. ANTICOAGULANTS MARKET VALUE CHAIN ANALYSIS 10.1. ANTICOAGULANTS INDUSTRIAL CHAIN ANALYSIS 10.2. ANTICOAGULANTS KEY RAW MATERIALS ANALYSIS 10.2.1. Key Raw Materials 10.2.2. Price Trend of Key Raw Materials 10.2.3. Key Suppliers of Raw Materials 10.3. MARKETING CHANNEL 10.3.1. Direct Marketing 10.3.2. Indirect Marketing 10.3.3. Distributors/Traders 10.4. CONSUMER ANALYSIS 10.4.1. Consumer 1 10.4.2. Consumer 2 10.4.3. Consumer 3 10.4.4. Consumer 4

• Bayer HealthCare
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Daiichi Sankyo
• Johnson & Johnson
• Sanofi
• Abbott Laboratories
• Astrazeneca plc
• Merck & Co., Inc.
• Genentech Inc.
• GlaxoSmithKline plc
• Pfizer, Inc.
• Novartis AG.

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS

Esticast Logo

CORPORATE OFFICE

location  (US)

1055 West 7th Street, Los Angeles, CA 90017 (P) US

phone  +1-213-262-0704
location  (APAC Address)

Office No. 407, Navale Icon IT Park, Near Navale Bridge, Narhe, Pune, Maharashtra 411041

phone  +91-959-503-5024

COMPANY

SECURE ONLINE PAYMENTS

  • visa
  • mastercard
  • amex
  • discover

FOLLOW US

  • facebook
  • linkedin
  • phone
  • youtube
© 2022 | All Rights Reserved by Esticast Research & Consulting